Analyst Research

Report Title Price
Provider: Directors Deals Ltd.
$12.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sorin SpA Announces FDA 510 Clearance For New Sorin Connect Perfusion Charting System


Tuesday, 30 Jul 2013 10:15am EDT 

Sorin SpA announced that the 510 clearance for commercialization of Sorin CONNECTTM, Sorin Group's new and intuitive perfusion electronic charting system. The new Sorin CONNECT perfusion electronic charting system allows real-time data recording and trends visualization aimed to support clinicians and institutions in their perfusion management and documentation goals, during and after cardiac surgery. 

Company Quote

2.678
0.0060 +0.22%
10:15am EDT